Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL

Li Zhen He, Fabien Guidez, Caria Tribioli, Daniela Peruzzi, Martin Ruthardt, Arthur Z Zelent, Pier Paolo Pandolfi

Research output: Contribution to journalArticle

478 Citations (Scopus)

Abstract

Acute promyelocytic leukaemia (APL), associated with chromosomal translocations involving the retinoic acid receptor α gene (RARA) and the PML gene, is sensitive to retinoic acid (RA) treatment, while APL patients harbouring translocations between RARA and the PLZF gene do not respond to RA. We have generated PML-RARA and PLZF-RARA transgenic mice and show here that these fusion proteins play a critical role in leukaemogenesis and in determining responses to RA in APL, because PLZF-RARA transgenic mice develop RA-resistant leukaemia, while PML-RARA mice are responsive to RA treatment. We demonstrate that both PML-RARα and PLZF-RARα fusion proteins can act as transcriptional repressors and are able to interact with nuclear receptor transcriptional co-repressors, such as SMRT. PLZF-RARα, but not PML-RARα, can form, via its PLZF moiety, co-repressor complexes which are insensitive to RA. Histone deacetylase inhibitors such as Trichostatin A (TSA), in combination with RA, can overcome the transcriptional repressor activity of PML-RARα and PLZF-RARα as well as the unresponsiveness of PLZF-RARα- expressing leukaemic cells to RA. Thus, our findings unravel a crucial role for transcriptional silencing in APL pathogenesis and resistance to RA in APL.

Original languageEnglish (US)
Pages (from-to)126-135
Number of pages10
JournalNature Genetics
Volume18
Issue number2
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Co-Repressor Proteins
Acute Promyelocytic Leukemia
Tretinoin
Transgenic Mice
trichostatin A
Genes
Genetic Translocation
Retinoic Acid Receptors
Histone Deacetylase Inhibitors
Leukemia
Proteins

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

He, L. Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A. Z., & Pandolfi, P. P. (1998). Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nature Genetics, 18(2), 126-135. https://doi.org/10.1038/ng0298-126

Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. / He, Li Zhen; Guidez, Fabien; Tribioli, Caria; Peruzzi, Daniela; Ruthardt, Martin; Zelent, Arthur Z; Pandolfi, Pier Paolo.

In: Nature Genetics, Vol. 18, No. 2, 1998, p. 126-135.

Research output: Contribution to journalArticle

He, LZ, Guidez, F, Tribioli, C, Peruzzi, D, Ruthardt, M, Zelent, AZ & Pandolfi, PP 1998, 'Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL', Nature Genetics, vol. 18, no. 2, pp. 126-135. https://doi.org/10.1038/ng0298-126
He, Li Zhen ; Guidez, Fabien ; Tribioli, Caria ; Peruzzi, Daniela ; Ruthardt, Martin ; Zelent, Arthur Z ; Pandolfi, Pier Paolo. / Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. In: Nature Genetics. 1998 ; Vol. 18, No. 2. pp. 126-135.
@article{e2c55540888548bfac6403f7621e331e,
title = "Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL",
abstract = "Acute promyelocytic leukaemia (APL), associated with chromosomal translocations involving the retinoic acid receptor α gene (RARA) and the PML gene, is sensitive to retinoic acid (RA) treatment, while APL patients harbouring translocations between RARA and the PLZF gene do not respond to RA. We have generated PML-RARA and PLZF-RARA transgenic mice and show here that these fusion proteins play a critical role in leukaemogenesis and in determining responses to RA in APL, because PLZF-RARA transgenic mice develop RA-resistant leukaemia, while PML-RARA mice are responsive to RA treatment. We demonstrate that both PML-RARα and PLZF-RARα fusion proteins can act as transcriptional repressors and are able to interact with nuclear receptor transcriptional co-repressors, such as SMRT. PLZF-RARα, but not PML-RARα, can form, via its PLZF moiety, co-repressor complexes which are insensitive to RA. Histone deacetylase inhibitors such as Trichostatin A (TSA), in combination with RA, can overcome the transcriptional repressor activity of PML-RARα and PLZF-RARα as well as the unresponsiveness of PLZF-RARα- expressing leukaemic cells to RA. Thus, our findings unravel a crucial role for transcriptional silencing in APL pathogenesis and resistance to RA in APL.",
author = "He, {Li Zhen} and Fabien Guidez and Caria Tribioli and Daniela Peruzzi and Martin Ruthardt and Zelent, {Arthur Z} and Pandolfi, {Pier Paolo}",
year = "1998",
doi = "10.1038/ng0298-126",
language = "English (US)",
volume = "18",
pages = "126--135",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL

AU - He, Li Zhen

AU - Guidez, Fabien

AU - Tribioli, Caria

AU - Peruzzi, Daniela

AU - Ruthardt, Martin

AU - Zelent, Arthur Z

AU - Pandolfi, Pier Paolo

PY - 1998

Y1 - 1998

N2 - Acute promyelocytic leukaemia (APL), associated with chromosomal translocations involving the retinoic acid receptor α gene (RARA) and the PML gene, is sensitive to retinoic acid (RA) treatment, while APL patients harbouring translocations between RARA and the PLZF gene do not respond to RA. We have generated PML-RARA and PLZF-RARA transgenic mice and show here that these fusion proteins play a critical role in leukaemogenesis and in determining responses to RA in APL, because PLZF-RARA transgenic mice develop RA-resistant leukaemia, while PML-RARA mice are responsive to RA treatment. We demonstrate that both PML-RARα and PLZF-RARα fusion proteins can act as transcriptional repressors and are able to interact with nuclear receptor transcriptional co-repressors, such as SMRT. PLZF-RARα, but not PML-RARα, can form, via its PLZF moiety, co-repressor complexes which are insensitive to RA. Histone deacetylase inhibitors such as Trichostatin A (TSA), in combination with RA, can overcome the transcriptional repressor activity of PML-RARα and PLZF-RARα as well as the unresponsiveness of PLZF-RARα- expressing leukaemic cells to RA. Thus, our findings unravel a crucial role for transcriptional silencing in APL pathogenesis and resistance to RA in APL.

AB - Acute promyelocytic leukaemia (APL), associated with chromosomal translocations involving the retinoic acid receptor α gene (RARA) and the PML gene, is sensitive to retinoic acid (RA) treatment, while APL patients harbouring translocations between RARA and the PLZF gene do not respond to RA. We have generated PML-RARA and PLZF-RARA transgenic mice and show here that these fusion proteins play a critical role in leukaemogenesis and in determining responses to RA in APL, because PLZF-RARA transgenic mice develop RA-resistant leukaemia, while PML-RARA mice are responsive to RA treatment. We demonstrate that both PML-RARα and PLZF-RARα fusion proteins can act as transcriptional repressors and are able to interact with nuclear receptor transcriptional co-repressors, such as SMRT. PLZF-RARα, but not PML-RARα, can form, via its PLZF moiety, co-repressor complexes which are insensitive to RA. Histone deacetylase inhibitors such as Trichostatin A (TSA), in combination with RA, can overcome the transcriptional repressor activity of PML-RARα and PLZF-RARα as well as the unresponsiveness of PLZF-RARα- expressing leukaemic cells to RA. Thus, our findings unravel a crucial role for transcriptional silencing in APL pathogenesis and resistance to RA in APL.

UR - http://www.scopus.com/inward/record.url?scp=0031941912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031941912&partnerID=8YFLogxK

U2 - 10.1038/ng0298-126

DO - 10.1038/ng0298-126

M3 - Article

C2 - 9462740

AN - SCOPUS:0031941912

VL - 18

SP - 126

EP - 135

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 2

ER -